84 related articles for article (PubMed ID: 11601210)
1. [Function of B7/CD28 in anti-myeloma immunoreaction through activating T cells].
Guo L; Zhang X; Qiu Y
Zhonghua Xue Ye Xue Za Zhi; 1999 May; 20(5):235-8. PubMed ID: 11601210
[TBL] [Abstract][Full Text] [Related]
2. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
Damle NK; Klussman K; Leytze G; Linsley PS
J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
[TBL] [Abstract][Full Text] [Related]
3. CD28:B7 interactions promote T cell adhesion.
Turcovski-Corrales SM; Fenton RG; Peltz G; Taub DD
Eur J Immunol; 1995 Nov; 25(11):3087-93. PubMed ID: 7489747
[TBL] [Abstract][Full Text] [Related]
4. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
Galea-Lauri J; Darling D; Gan SU; Krivochtchapov L; Kuiper M; Gäken J; Souberbielle B; Farzaneh F
J Immunol; 1999 Jul; 163(1):62-70. PubMed ID: 10384100
[TBL] [Abstract][Full Text] [Related]
5. Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines.
Cayeux S; Beck C; Aicher A; Dörken B; Blankenstein T
Eur J Immunol; 1995 Aug; 25(8):2325-31. PubMed ID: 7545119
[TBL] [Abstract][Full Text] [Related]
6. Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells.
Tarte K; Zhang XG; Legouffe E; Hertog C; Mehtali M; Rossi JF; Klein B
J Immunol; 1999 Jul; 163(1):514-24. PubMed ID: 10384156
[TBL] [Abstract][Full Text] [Related]
7. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
[TBL] [Abstract][Full Text] [Related]
8. B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro.
Lu ZY; Condomines M; Tarte K; Nadal L; Delteil MC; Rossi JF; Ferrand C; Klein B
Exp Hematol; 2007 Mar; 35(3):443-53. PubMed ID: 17309825
[TBL] [Abstract][Full Text] [Related]
9. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
Mandelbrot DA; Oosterwegel MA; Shimizu K; Yamada A; Freeman GJ; Mitchell RN; Sayegh MH; Sharpe AH
J Clin Invest; 2001 Apr; 107(7):881-7. PubMed ID: 11285307
[TBL] [Abstract][Full Text] [Related]
10. CD28 interactions with either CD80 or CD86 are sufficient to induce allergic airway inflammation in mice.
Mathur M; Herrmann K; Qin Y; Gulmen F; Li X; Krimins R; Weinstock J; Elliott D; Bluestone JA; Padrid P
Am J Respir Cell Mol Biol; 1999 Oct; 21(4):498-509. PubMed ID: 10502560
[TBL] [Abstract][Full Text] [Related]
11. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
Fenton RG; Turcovski-Corrales SM; Taub DD
J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
[TBL] [Abstract][Full Text] [Related]
12. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.
Lanier LL; O'Fallon S; Somoza C; Phillips JH; Linsley PS; Okumura K; Ito D; Azuma M
J Immunol; 1995 Jan; 154(1):97-105. PubMed ID: 7527824
[TBL] [Abstract][Full Text] [Related]
13. Malignant plasma cell lines express a functional CD28 molecule.
Zhang XG; Olive D; Devos J; Rebouissou C; Ghiotto-Ragueneau M; Ferlin M; Klein B
Leukemia; 1998 Apr; 12(4):610-8. PubMed ID: 9557621
[TBL] [Abstract][Full Text] [Related]
14. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules.
Yang G; Hellström KE; Hellström I; Chen L
J Immunol; 1995 Mar; 154(6):2794-800. PubMed ID: 7533183
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 12 and B7/CD28 interaction synergistically upregulate interleukin 10 production by human T cells.
Peng X; Kasran A; Ceuppens JL
Cytokine; 1997 Jul; 9(7):499-506. PubMed ID: 9237812
[TBL] [Abstract][Full Text] [Related]
16. Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28.
Saito K; Sakurai J; Ohata J; Kohsaka T; Hashimoto H; Okumura K; Abe R; Azuma M
J Immunol; 1998 May; 160(9):4225-31. PubMed ID: 9574523
[TBL] [Abstract][Full Text] [Related]
17. The CD28 ligand, B7, enhances IL-2 production by providing a costimulatory signal to T cells.
Norton SD; Zuckerman L; Urdahl KB; Shefner R; Miller J; Jenkins MK
J Immunol; 1992 Sep; 149(5):1556-61. PubMed ID: 1380533
[TBL] [Abstract][Full Text] [Related]
18. Activation of human T cell lymphotropic virus type I-infected T cells is independent of B7 costimulation.
Scholz C; Freeman GJ; Greenfield EA; Hafler DA; Höllsberg P
J Immunol; 1996 Oct; 157(7):2932-8. PubMed ID: 8816399
[TBL] [Abstract][Full Text] [Related]
19. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7.
Damle NK; Klussman K; Leytze G; Ochs HD; Aruffo A; Linsley PS; Ledbetter JA
Cell Immunol; 1993 Apr; 148(1):144-56. PubMed ID: 7684325
[TBL] [Abstract][Full Text] [Related]
20. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
Zhou T; Weaver C; Linsley PS; Mountz JD
Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
